The right to participate in research studies.
The right to participate in research studies.
复制标题
参与研究的权利。
DOI：
--
复制
发表时间：
1993
期刊：
影响因子：
--
通讯作者：
M. Elks
中科院分区：
文献类型：
--
作者：
M. Elks
最初成立了在科学研究中使用人类受试者的机构审查委员会，重点是保护人类受试者免受研究风险。然而，近年来显而易见的是，保护个人获得参与研究的好处的权利也很重要。这些包括但不限于某些实验药物或治疗、更密切的监测、免费护理或直接报酬以及针对特定人群的研究结果的社会效益。长期以来，各自的机构审查委员会一直让研究人员意识到保护受试者的必要性，现在他们还必须关注将个人纳入其中的额外负担，以及为保护某些人群（包括艾滋病患者、妇女、少数民族、儿童和老年人）的安全和权利而可能采取的更大努力。必须额外注意设计适当的研究，招募适当的人群，制定完整但可理解且非威慑性的知情同意书，并努力确保参与者知情。
Institutional review boards for the use of human subjects in scientific studies were initially established to focus on protection of human subjects from the risks of research. It has become evident in recent years, however, that it is also important to protect the rights of individuals to have access to the benefits of research participation. These include, but are not limited to, certain experimental drugs or treatments, closer monitoring, free care or direct remuneration, and societal benefits of results of studies on specific populations. Researchers, so long sensitized by their respective institutional review boards to the need for protection of the subjects, now must also focus on the added burden of efforts to include individuals and the increased efforts it may take to protect the safety and rights of certain populations, including patients with AIDS, women, minorities, children, and the elderly. Additional care must be taken to design appropriate studies, recruit an appropriate spectrum of the population, craft a complete yet understandable and nondeterent informed consent form, and make efforts to assure that participants are informed.